Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
CPT Codes for COVID-19 Vaccinations, Encounters
The Centers for Medicare and Medicaid Services (CMS) explained reimbursement codes to use for COVID-19 vaccinations and patient encounters in their August 19, 2021 listserv.
Read this excerpt from their bulletin issue, COVID-19 Vaccine News: Recent updates regarding additional doses of the COVID-19 vaccine:
News Article updated on 08/20/2021 -
Transgender Health Program Integrated Into HIV Prevention and Care
The Rutgers New Jersey Medical School created a transgender health program and integrated it into their Infectious Disease Practice. The program conducted community outreach to engage transgender men and women in care, trained all staff on gender affirming care, hired transgender staff, provided gender affirming care and hormone treatments onsite, and offered mental health support to patients.Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
-
RSR Upload Completeness Report Training Module
Explanation of the RSR Upload Completeness Report generated by the RSR Web System that reads uploaded XML files and generates reports with a full breakdown of client-level data.Resource updated 09/19/2023
-
Four Things to Know About Open Enrollment 2022
-
Ryan White Part A-F Awards Announced for FY21
From the HRSA HIV/AIDS Bureau Update: Special Bulletin - 10/5/21
News Article updated on 10/06/2021 -
Office Hours: A New TA Platform for Data Support
From the DISQ Listserv - Dear RWHAP community
News Article updated on 09/10/2021 -
Rapid ART: An Essential Strategy for Ending the HIV Epidemic
What HIV care providers can do to create a rapid ART program to get HIV clients on treatment the same day as a diagnosis.Resource updated 09/19/2023
-
Rapid ART Playbook Outlines Steps to Implementation
Guide on implementing rapid ART the administration of antiretroviral therapy (ART) as quickly as possible and ideally on the same day as an HIV diagnosis/clinic visit.Blog updated 03/03/2022
-
TAP-in EHE Webinar Series
Recordings of the TAP-in webinars on topics critical to the Ending the HIV Epidemic Initiative.Resource updated 05/23/2023
-
Needs Assessment Tool Series: Focus Groups
-
HRSA Revises RWHAP Policy Notice on Eligibility Determinations
In October 2021, HRSA's HIV/AIDS Bureau revised its client eligibility and recertification policy for the Ryan White HIV/AIDS Program.
News Article updated on 11/02/2021 -
HRSA Releases New Fact Sheets on RWHAP Clients
Ten fact sheets on client populations getting care from the Ryan White HIV/AIDS Program (RWHAP) a
News Article updated on 06/30/2021 -
Use of Social Media and Mobile Technology as Essential Tools for EHE
Strategies to engage hard-to-reach youth and young adults through use of social media and related technologies.Resource updated 03/15/2023
-
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
Medical Monitoring Project 2019-2020 Data on HIV Care Access and Health Outcomes
In the U.S., almost all people with HIV have some type of health insurance coverage (pub
News Article updated on 08/09/2021 -
Moving Beyond Data Completeness: Ensuring RSR Data Reflect Services Being Provided
Review of 2021 RSR data and data quality issues.Resource updated 12/21/2023
-
Preparing for the RSR: A Yearlong Activity
Description of year-round activities and best practices in preparing for the Ryan White HIV/AIDS Program Services Report (RSR).Resource updated 09/19/2023
-
RSR Frequently Asked Questions
These FAQs are drawn from DISQ's webinars and other engagement with recipients. If your question isn't covered, contact us via our TA Request Form or DISQ email account.Resource updated 09/19/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023